Cerebral abscess in a multiple sclerosis patient during treatment with natalizumab

被引：0
|
作者：
B. Durmus
J. Van Goethem
A. Vercruyssen
G. De la Meilleure
C. Jadoul
B. Willekens
机构：
[1] AZ Nikolaas,Department of Neurology
[2] AZ Nikolaas,Department of Radiology
[3] Moerlandstraat 1,Department of Neurology
[4] 9100,Laboratory of Experimental Hematology
[5] Department of Radiology,undefined
[6] Antwerp University Hospital,undefined
[7] Antwerp University Hospital,undefined
[8] University of Antwerp,undefined
来源：
Acta Neurologica Belgica | 2020年 / 120卷
关键词：
Natalizumab; Abscess; Bacterial infection; Multiple sclerosis; Immune system;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 217
页数：2
相关论文
共 50 条
  • [31] PHARMACOECONOMIC ASSESSMENT OF NATALIZUMAB IN THE TREATMENT OF MULTIPLE SCLEROSIS
    Matveev, N., V
    Sabanov, A., V
    VALUE IN HEALTH, 2012, 15 (04) : A145 - A145
  • [32] Melanoma complicating treatment with natalizumab for multiple sclerosis
    Mullen, John T.
    Vartanian, Timothy K.
    Atkins, Michael B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 647 - 648
  • [33] Considerations on Discontinuing Natalizumab for the Treatment of Multiple Sclerosis
    Berger, Joseph R.
    Centonze, Diego
    Comi, Giancarlo
    Confavreux, Christian
    Cutter, Gary
    Giovannoni, Gavin
    Gold, Ralf
    Hartung, Hans-Peter
    Lublin, Fred
    Miravalle, Augusto
    Montalban, Xavier
    O'Connor, Paul
    Olsson, Tomas
    Polman, Chris H.
    Stuve, Olaf
    Wolinsky, Jerry S.
    Ziemssen, Tjalf
    ANNALS OF NEUROLOGY, 2010, 68 (03) : 409 - 411
  • [34] Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab
    Valenzuela, Reuben Mari
    Pula, John H.
    Garwacki, Dennis
    Cotter, John
    Kattah, Jorge C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 340 (1-2) : 109 - 111
  • [35] Biomarkers for monitoring natalizumab treatment in multiple sclerosis
    Bringeland, G. H.
    Vedeler, C. A.
    Myhr, K. M.
    Gavasso, S.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 901 - 901
  • [36] UNUSUAL DETERIORATION IN A PATIENT WITH MULTIPLE SCLEROSIS ON NATALIZUMAB THERAPY
    Gattringer, Thomas
    Enzinger, Christian
    Khalil, Michael
    Schwingenschuh, Petra
    Pichler, Alexander
    Moser, Alexander
    Graninger, Winfried
    Ernst, Christina
    Haybaeck, Johannes
    Fazekas, Franz
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2014, 1 (01):
  • [37] RISK STRATIFICATION AND PATIENT COUNSELING FOR NATALIZUMAB IN MULTIPLE SCLEROSIS
    Fox, Robert J.
    Rudick, Richard A.
    NEUROLOGY, 2012, 78 (06) : 436 - 437
  • [38] Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab
    Durrieu, Genevieve
    Dardonville, Quentin
    Clanet, Michel
    Montastruc, Jean-Louis
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (01) : 125 - 126
  • [39] Severe anaemia in a patient with multiple sclerosis treated with natalizumab
    Simone, A. M.
    Ferraro, D.
    Vitetta, F.
    Federzoni, L.
    Marasca, R.
    Bonacorsi, G.
    Nichelli, P. F.
    Sola, P.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 243 - 243
  • [40] SEVERE ANEMIA IN A PATIENT WITH MULTIPLE SCLEROSIS TREATED WITH NATALIZUMAB
    Seibert, Julie B.
    Alvarez, Enrique
    NEUROLOGY, 2015, 84 (08) : 861 - 861
12345